Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56
United States Fiscal year ends December CIK 0001819790 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Seshadri Neervannan
4 Sep 2026
Chief Operating Officer
Sold on a plan
4,564
$85.00
$387.94K
Bobak R. Azamian
4 Sep 2026
President/CEO and Board Chair
Sold on a plan indirect
2,900
$91.27
$264.68K
Bobak R. Azamian
4 Sep 2026
President/CEO and Board Chair
Sold on a plan indirect
7,100
$90.27
$640.92K
Elizabeth Yeu Lin
4 Sep 2026
Chief Medical Officer
Sold on a plan indirect
1,590
$90.00
$143.10K
Elizabeth Yeu Lin
4 Sep 2026
Chief Medical Officer
Sold on a plan indirect
1,590
$85.00
$135.15K
Elizabeth Yeu Lin
4 Sep 2026
Chief Medical Officer
Sold on a plan
5,386
$90.00
$484.74K
Elizabeth Yeu Lin
4 Sep 2026
Chief Medical Officer
Sold on a plan
5,387
$85.00
$457.90K
Elizabeth Yeu Lin
2 Sep 2026
Chief Medical Officer
Sold on a plan indirect
1,590
$80.00
$127.20K
Elizabeth Yeu Lin
2 Sep 2026
Chief Medical Officer
Sold on a plan
5,387
$80.00
$430.96K
Bobak R. Azamian
2 Sep 2026
President/CEO and Board Chair
Sold on a plan indirect
10,000
$80.06
$800.60K
Elizabeth Yeu Lin
1 Sep 2026
Chief Medical Officer
Sold on a plan
4,601
$73.86
$339.83K
Bobak R. Azamian
17 Jun 2026
President/CEO and Board Chair
Sold on a plan indirect
5,418
$61.81
$334.89K
Bobak R. Azamian
17 Jun 2026
President/CEO and Board Chair
Sold on a plan indirect
4,582
$61.24
$280.60K
William J Phd Link
15 Jun 2026
Director
Sold on a plan
1,928
$62.94
$121.35K
William J Phd Link
15 Jun 2026
Director
Sold on a plan
10,572
$61.97
$655.15K
Katherine Goodrich
15 Jun 2026
Director
Sold on a plan
2,954
$62.08
$183.38K
Seshadri Neervannan
20 Mar 2026
Chief Operating Officer
Sold on a plan
2,989
$66.75
$199.52K
William J Phd Link
16 Mar 2026
Director
Sold on a plan
493
$69.75
$34.39K
William J Phd Link
16 Mar 2026
Director
Sold on a plan
8,378
$69.03
$578.33K
William J Phd Link
16 Mar 2026
Director
Sold on a plan
3,629
$68.09
$247.10K
Seshadri Neervannan
4 Mar 2026
Chief Operating Officer
Sold on a plan
8,366
$76.67
$641.42K
Dianne C. Whitfield
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
893
$82.93
$74.06K
Dianne C. Whitfield
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
835
$81.90
$68.39K
Dianne C. Whitfield
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
8,122
$80.71
$655.53K
Dianne C. Whitfield
2 Jan 2026
Chief Human Resources Officer
Sold on a plan
5,715
$80.09
$457.71K
Bobak R. Azamian
24 Dec 2025
President/CEO and Board Chair
Sold on a plan indirect
557
$83.54
$46.53K
Bobak R. Azamian
24 Dec 2025
President/CEO and Board Chair
Sold on a plan indirect
5,443
$82.41
$448.56K
Dianne C. Whitfield
16 Dec 2025
Chief Human Resources Officer
Sold on a plan
7,397
$80.10
$592.50K
William J Phd Link
15 Dec 2025
Director
Sold on a plan indirect
4,766
$81.50
$388.43K
William J Phd Link
15 Dec 2025
Director
Sold on a plan indirect
5,680
$80.71
$458.43K
William J Phd Link
15 Dec 2025
Director
Sold on a plan
1,148
$82.39
$94.58K
William J Phd Link
15 Dec 2025
Director
Sold on a plan
6,306
$81.75
$515.52K
William J Phd Link
15 Dec 2025
Director
Sold on a plan
5,046
$80.80
$407.72K

What was left out

Form 4 filings counted 60
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 3
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 292,795
History held since 20 Oct 2020